Dong Xiao Zhang

Title: The Innovations of Dong Xiao Zhang

Introduction

Dong Xiao Zhang is a prominent inventor based in Burlingame, California. He has made significant contributions to the field of biotechnology, particularly in the development of neuregulin-related ligands. With a total of three patents to his name, Zhang's work has the potential to impact various therapeutic areas.

Latest Patents

Zhang's latest patents include innovative methods for stimulating ErbB4 receptor phosphorylation. This invention focuses on a novel neuregulin-related ligand known as NRG3, which includes fragments and variants that are new members of the neuregulin family of compounds. The invention also outlines methods for producing NRG3, characterized by its extracellular domain, transmembrane domain, and cytoplasmic domain. Additionally, Zhang's patents cover isolated nucleotide sequences encoding these polypeptides, expression vectors containing the sequences, and recombinant host cells transformed with the vectors. The scope of his inventions also includes ErbB4 receptor-specific neuregulin-related ligand antibodies and their uses.

Career Highlights

Dong Xiao Zhang is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative research and development. His work at Genentech has allowed him to further his research and contribute to groundbreaking advancements in the field.

Collaborations

Throughout his career, Zhang has collaborated with notable colleagues, including Paul J. Godowski and Melanie Rose Mark. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Dong Xiao Zhang's contributions to biotechnology through his patents and work at Genentech highlight his role as a significant inventor in the field. His innovative approaches to neuregulin-related ligands have the potential to lead to important advancements in medical science.